Theralase Technologies Inc. V.TLT

It takes money to advance oncology R&D

[ScienceFirst]

The pp only means that they need/want to advance milestones (Rutherrin, GBM, NSCLC, NML, additional CSS, etc ...) before NMIBC FDA decision is announced and my take is that Breakthrough designation has not yet been been submitted but that it will by end of Q1 as they alluded that they were awaiting on whether more patients (we had 6 more coming up in a very short timeframe after p#26) on potentially guidance from the FDA or have been waiting for urologists reports.  No matter what, they know where they're heading.  The next few months will confirm these advances.  

Remember that for GBM and NSCLC, we must hear about MSAB nominations.  That would be THE signal that we have KOL experts that back the potential of our ACT platform in these 2 complex and challenging indications that are worth B$$$.

[Rumpl3StiltSkin]

SF, Do we kow, for sure, that they need more pp money $$ right now? And that explains the weird trading? I agree it will all be worth it, and fairly soon.  :-)

[DJDawg]

I'm not so sure. I have a friend who got me on to TLT and he got a call about the PP the last time, to see if he was interested. No calls or emails from Roger yet. My hunch is that the swing players just assumed but could be wrong. There was a day a month back that 500,000 shares moved and price didn't change which I interpret to mean that there are people washing trades between accounts

[enriquesuave]

So far no calls. I can confirm I invested in last PP after a phone call.  For sure they will need money by latest end of May.  How it will come is anyone's guess.  If they submitted BTD request then we may soon get an answer. Regardless of whether they are waiting on more data to submit, or already have done so, I think that they can at anytime update FDA on new data which will

[CancerSlayer]

  I agree...I think we are closer than many realize to qualifying for an accelerated approval (AA), especially when you consider we would be providing additional interim data re: clinical efficacy as opposed to providing just surrogate endpoint data.   There has been a growing cost for AA drugs & many states/Medicaid officials are putting increased pressure on the Feds to

[ScienceFirst]

Novartis is already targeting NMIBC and NSCLC.  So not necessarily the best candidate, unless they decide otherwise. February 23, 2023 PBF-509 by Novartis for Bladder Cancer: Likelihood of Approval PBF-509 is under clinical development by Novartis and currently in Phase II for Bladder Cancer. According to GlobalData, Phase II drugs for Bladder

[chry200030]

How close is closer than anyone realizes. I was expecting AA by March 01. We are now March 07.

[Galaxym31]

Real stock traders dont decend to this kind of stock .

[Rumpl3StiltSkin]

I think it is also possible that some of these recent pp shares are now available to sell.

[ScienceFirst]

I have no official proof that a pp is in the making but yesterday's sudden drop had all the hallmarks of one.  If so, it's quite possible that they would have a base of new profile of investors (those that can move us higher).  They probably received interest from ASCO-GU, etc ... At this point in time, with what's coming up, with now having reached the minimum threshold

[FGPstock]

  this additional indication talk is just a bunch more smoke. They have discussed it for 7+ years and the reality is, no one is going to invest in additional indications until NMIBC is proved. If anyone . Per the Md&a's, Tlt is quoted 3-5 times that btd was to b Received in dec 2022. Also, the Covid research was supposed completed q4 2022. The Covid excuse doesn't work anymore

[Rumpl3StiltSkin]

Take yer pick FGP, Either they are spending the dough $$ to make GLP happen, which will lead to these other Phase 1s, probably small/cheap Canada only studies, or they have the $$ in the coffers to make it to Sept before looking for the next pp.  Bashers gotta bash, right?

[FGPstock]

Rumpy, if TLT could ever stick to their own set timelines, we wouldn't be having this conversation. The projected both Covid and BTD to b completed in Dec 2022, Their words, not mine. There is a reason the stock is at .30 cents and they have a hard time getting funding as their track recod isn't very good. PPL complain about manipulation, shorting, etc, but there is no meaningful short

[Rumpl3StiltSkin]

I don't believe you Goldie(FGP), You've been on this board, and CEO.ca(KillerB), for years under all sorts of monikers. You are either a paid basher or otherwise have a hardon for a former TLT officer. You have a different agenda. GL

[CAinPlap]

Yes despite being corrected several times on BTD designation application, he continues to say that TLT said we would have it in Dec 2022 rather than the factual would be in a position to apply for it.   My only beef may be if they are waiting to apply until reaching 34 - 37 patients, that we could have been updated. Perhaps this will be part of the next update.

[ScienceFirst]

Our dinosaur and grumbler-in-chief FGPStuck is at it again!!! It is TLT, not this clown, that brought us the the door of Breakthrough Therapy designation and with superior efficacy data over competition.  Not bad. This clown obviously talk like an armchair quarterback that delivered nothing in his life. What a grumbler.  By chance, TLT is not run by him!  

[N0taP00p]

After 10 plus years of waiting, you get emotionally tied to a stock and stop being objective. You not only start drinking the Koolaid you even CREATE your own flavours every day. Been there. The next thing you do is throw virtual tantrums at anyone who has different views than you.  You even delve into conspiracy theories about powerful beings called bashers that can ruin your dreams with one

[gebremeskel]

Don't flatter yourself p00p. No one thinks you're powerful just irritating.  You repeat thr same tiresome basher tropes we've all heard from you over and over again over the years under your different aliases No one thnks you can ruin our dreams. The best you can do is get on our nerves.

[ScienceFirst]

Couldn't agree more with you Gebremeskel. And some would be more advised to focus on the processes instead of the daily share price, to have the appropriate expectations.  They would be less deceived and would be more confident that we will get there.   Putting the cart before the horse is not really a brilliant idea.

[skys1]

Well said gebremeskel !

[StevenBirch]

That's why I have him on ignore, he uses words like hope, but and objective when an honest person with his doubts would sell and move on. The only thing I agree with him on is he has the right to his opinion and I have the right not to see it.